1. Introduction {#sec0005}
===============

Implementation of effective infection prevention and control (IPC) measures is needed to support global capacity building to limit the transmission of coronavirus disease 2019 (COVID-19) and mitigate its impact on health systems. The COVID-19 pandemic has shown a high incidence of transmissibility of health care-associated infections and outbreaks affecting healthcare workers (HCWs) who are at the forefront of these crises, illustrating the importance of being prepared [@bib0005].

2. Methods {#sec0010}
==========

We assessed the perceptions of infection preventionists on the current global IPC preparedness measures for COVID-19. Between 26 February 2020, and 20 March 2020, we conducted a cross-sectional self-administered web-based survey study to gain a rapid insight into the preparedness of healthcare facilities and investigate current global practices and perceptions among IPC professionals concerning the prevention and control of COVID-19. All IPC professionals working in healthcare facilities preparing for the detection, investigation and management of confirmed and suspected COVID-19 patients were invited to participate. Descriptive statistics were used to analyse the survey data. Differences between regions and income groups were tested using Pearson\'s *χ* ^2^ test for categorical variables.

3. Results and discussion {#sec0015}
=========================

A total of 349 responses were received; 10 were excluded as no demographic information was provided. The 339 eligible responses were from 63 countries across six regions: Africa, 113 (33.3%); Europe, 92 (27.1%); Southeast Asia, 72 (21.2%); the Americas, 33 (9.7%); Eastern Mediterranean, 15 (4.4%); Western Pacific, 14 (4.1%). Based on the 2020 World Bank list of gross national income per capita, they represented 113 (33.3%) responses from high-income countries (HICs), 99 from upper-middle-income countries (UMICs) (29.2%), 71 from lower-middle-income countries (LMICs) (20.9%) and 56 from low-income countries (LICs) (16.5%) (<https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups>). Response rate by profession included 190 IPC physicians (56.0%); 113 IPC nurses (33.3%) and 36 other professionals, including pharmacists and public health specialists. Healthcare facilities represented in the survey were mostly tertiary care centres (46%). Of all participants, 66.6% were aware of the existence of national guidelines to prevent COVID-19 ([Table 1](#tbl0005){ref-type="table"} ). A shortage of personal protective equipment (PPE) supplies was reported by 48% (ranging from 64.2% in LICs to 27.4% in HICs). When asked about the availability of PPE supplies, 163 of 339 \[48%; 95% confidence interval (CI), 42.7--53.4\] respondents reported a shortage of supplies \[64.2% (36/56; 95% CI, 51.7--76.8) in LICs compared with 27.4% (31/113; 95% CI, 19.2--35.6) in HICs\]. A total of 41.5% of respondents considered that the media had an impact on guideline development and 63.6% believed that guidelines were based on maximum security rather than on evidence-based recommendations; thus, uncertainties regarding the transmission modes of COVID-19 continue to generate controversy [@bib0010], [@bib0015].Table 1Geographical comparison of healthcare facilities and IPC preparedness for patients with COVID-19, results from a survey of representatives from 339 responses in 63 countries worldwide, February--March 2020.Table 1No. (%) of respondentsComparison between regionsAfricaAmericasEast MediterraneanEuropeSoutheast AsiaWestern Pacific*P*-value*n* (%)*n* (%)*n* (%)*n* (%)*n* (%)*n* (%)*n* (%)COVID-19 guidelines National guidelines226 (66.67)53 (46.9)22 (66.67)13 (86.67)65 (70.65)60 (83.33)13 (92.86)\<0.001 Local guidelines182 (53.69)40 (35.4)21 (63.64)8 (53.33)42 (45.65)62 (86.11)9 (64.29)\<0.001Guidelines recommend the use of PPE Guidelines address PPE214 (63.13)60 (53.1)20 (60.61)9 (60)51 (55.43)63 (87.5)11 (78.57)\<0.001 Facemask272 (80.24)87 (76.99)25 (75.76)11 (73.33)70 (76.09)65 (90.28)14 (100)0.06 Gown251 (74.04)81 (71.68)22 (66.67)9 (60)65 (70.65)60 (83.33)14 (100)0.04 Cap182 (64.31)66 (68.75)8 (29.63)5 (50)42 (60)57 (86.36)4 (28.57)\<0.001 Eye protection245 (72.27)75 (66.37)22 (66.67)10 (66.67)65 (70.65)60 (83.33)13 (92.86)0.07 Gloves266 (97.08)90 (96.77)26 (96.3)10 (100)65 (95.59)62 (98.41)13 (100)0.004Preparedness effort Hand hygiene259 (96.28)86 (93.48)24 (92.31)10 (100)63 (98.44)65 (98.48)11 (100)0.34 Training HCWs235 (86.72)67 (72.83)24 (85.71)10 (100)59 (92.19)64 (96.97)11 (100)\<0.001 PPE in community144 (53.33)51 (55.43)8 (29.63)1 (10)27 (42.19)51 (77.27)6 (54.55)\<0.001 PPE in the outpatient setting243 (91.35)80 (86.96)21 (84)10 (100)56 (90.32)65 (98.48)11 (100)0.07Environmental decontamination Use of hypochlorite199 (73.7)74 (80.43)13 (48.15)5 (50)40 (62.5)61 (92.42)6 (54.55)\<0.001 Automated disinfection system100 (37.04)12 (13.04)6 (22.22)4 (40)25 (39.06)52 (78.79)1 (9.09)\<0.001[^3]

The belief that opinions expressed by the media influenced the choices made for national/local guidelines or the preparedness plans for COVID-19 was confirmed by 41.5% (105/252; 95% CI, 35.4--47.5) of respondents. More than half of them (161/253; 63.6%; 95% CI, 57.7--69.5) also believed that national/local guidelines were based predominantly on maximum security, rather than on evidence-based recommendations. HICs were more likely than LICs to report sufficient preparedness (51/71; 71.8%; 95% CI, 61.3--82.2 vs. 14/45; 31%; 95% CI, 17.5--44.6; *P*  \< 0.01).

Participants reported that national or local COVID-19 guidelines recommended mainly the use of N95/FFP2 masks (120/267; 44.9%), followed by surgical masks (77/267; 28.8%) or a combination of the two in specific situations, respectively (39/267; 14.6%), and powered air-purifying respirators (PAPR) (21/267; 7.9%) ([Table 2](#tbl0010){ref-type="table"} ). A total of 74.3% (188/253; 95% CI, 68.9--79.6) believed that the use and heightened focus on wearing facemasks creates a misplaced feeling of safety, possibly reducing attention on other IPC measures, such as hand hygiene.Table 2Protective equipment (PPE) included in national or local COVID-19 guidelines.Table 2No. (%) of respondentsComparison between regionsAfricaAmericasEast MediterraneanEuropeSoutheast AsiaWestern Pacific*P*-value*n* (%)*n* (%)*n* (%)*n* (%)*n* (%)*n* (%)*n* (%)Face mask*n* = 267 FFP16 (2.25)2 (2.35)0 (0)0 (0)3 (4.41)1 (1.54)0 (0)0.16 N95/FFP2120 (44.94)36 (42.35)13 (52)7 (70)38 (55.88)20 (30.77)6 (42.86)\<0.001 Respirators21 (7.87)8 (9.41)1 (4)0 (0)12 (17.65)0 (0)0 (0)\<0.001 Surgical mask and N95/FFP239 (14.61)1 (1.18)1 (4)0 (0)2 (2.94)33 (50.77)2 (14.29)\<0.001 Surgical mask77 (28.84)36 (42.35)10 (40)3 (30)11 (16.18)11 (16.92)6 (42.86)\<0.001 Other4 (1.5)2 (2.35)0 (0)0 (0)2 (2.94)0 (0)0 (0)\<0.001Gown type*n* = 242 Short-sleeved plastic27 (11.16)4 (5.41)2 (9.09)0 (0)1 (1.59)20 (33.33)0 (0)\<0.001 Long-sleeved water repellent170 (70.25)52 (70.27)20 (90.91)8 (88.89)55 (87.3)23 (38.33)12 (85.71)\<0.001 Coverall29 (11.98)18 (24.32)0 (0)1 (11.11)7 (11.11)1 (1.67)2 (14.29)\<0.001 Long-sleeved water resistant and short-sleeved plastic16 (6.61)0 (0)0 (0)0 (0)0 (0)16 (26.67)0 (0)\<0.001Cap type*n* = 181 Cap covering the head and neck79 (43.65)44 (67.69)4 (50)2 (40)19 (45.24)6 (10.53)4 (100)\<0.001 Cap covering the head only102 (56.35)21 (32.31)4 (50)3 (60)23 (54.76)51 (89.47)0 (0)\<0.001Eye protection*n* = 241 'Ski' googles68 (28.22)17 (23.29)5 (22.73)1 (10)15 (23.44)29 (48.33)1 (8.33)\<0.001 Face shield135 (56.02)47 (64.38)8 (36.36)8 (80)37 (57.81)28 (46.67)7 (58.33)\<0.001 Other38 (15.77)9 (12.33)9 (40.91)1 (10)12 (18.75)3 (5)4 (33.33)\<0.001Gloves*n* = 274 No gloves8 (2.92)3 (3.23)1 (3.7)0 (0)3 (4.41)1 (1.59)0 (0)0.22 Double gloving48 (17.52)28 (30.11)1 (3.7)1 (10)14 (20.59)2 (3.17)2 (15.38)\<0.001 Single pair disposable218 (79.56)62 (66.67)25 (92.59)9 (90)51 (75)60 (95.24)11 (84.62)\<0.001Shoe cover*n* = 275 Shoe and lower leg cover50 (18.18)30 (32.26)0 (0)0 (0)11 (16.18)5 (7.81)4 (30.77)\<0.001 Shoe cover99 (36)30 (32.26)6 (22.22)2 (20)16 (23.53)45 (70.31)0 (0)\<0.001 No shoe cover126 (45.82)33 (35.49)21 (77.77)8 (80)41 (60.29)14 (21.87)9 (69.23)\<0.001[^4]

At the height of the outbreak, uncertainties about transmission led many institutions to impose airborne precautions while considerable variation was observed amongst international guidelines. The main transmission modes of COVID-19 virus occur via respiratory droplets and contact [@bib0020], [@bib0025]. More uniformity is needed at the international level on PPE recommended for care of suspected or confirmed COVID-19 patients, based on available evidence and the most effective IPC strategies. The PPE doffing process is critical to keep HCWs safe, and further research on the science of human factors and HCW behaviour with respiratory protection safety is needed.

4. Conclusions {#sec0020}
==============

The COVID-19 global pandemic has shown the importance of building more resilient healthcare systems with effective IPC as key to avoid or mitigate outbreak impact. Health organizations should jointly evaluate the available evidence and develop a uniform policy on the appropriate PPE to be used. Strengthening of coordinated international efforts is urgent to address the challenges related to the major PPE shortage in healthcare facilities, particularly the lack of resources in low-income settings, and to improve reliable communication through the media. National health authorities should ramp up the implementation of IPC measures and focus on long-term preparedness and readiness for future pandemics, which likely requires government funds rather than reliance on healthcare institutions.
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